CHMP5 and sarcoidosis: The 6 patients (excluded from both cohorts) having a previous articular sarcoidosis and those who developed a flare or sarcoidosis after vaccination [19,20,21] confirm the normal incidence of the disease diagnosed in our department and raise questions about the significance of the high level of anti-Spike antibodies and the role of Spike protein in the occurrence of inflammatory articular manifestations.